The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs

Psychopharmacology

Volumn 135, Issue 2, 1998, Pages 107-118

  Mele, Andrea ^a,c   Wozniak, Krystyna M ^b   Hall, F S ^b   Pert, Agu ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Phencyclidine; Rat; Rotational behavior; Striatal dopamine

Indexed keywords

DEXOXADROL; DIZOCILPINE; N ALLYLNORMETAZOCINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEDIAL FOREBRAIN BUNDLE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; HALLUCINOGENS; MALE; MICRODIALYSIS; MOTOR ACTIVITY; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOTYPED BEHAVIOR;

EID: 0031973450     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050491     Document Type: Article

References (110)

1. Aguayo LG, Albuquerque EX (1986) Blockade and recovery of the acetylcholine receptor produced by a thienyl analog of phencyclidine: influence of voltage, temperature, frequency of stimulation and conditioning pulse duration. J Pharmacol Exp Ther 239: 25-31
2. 3H] 1-[2-(2-Thienyl) cyclohexyl] piperidine labels two high affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptuke complex. Synapse 8: 289-300
3. Albuquerque EX, Tsai M-C, Aronstam RS, Eldefrawi AT, Elderfrawi ME (1980) Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotine receptor. Mol Pharmacol 18: 167-178
4. Albuquerque EX, Aguayo LG, Warwick JE, Weinstein H, Glick SD, Maayani S, Ickowicz RK, Blaustein MP (1981) The behavioral effects of phencyclidines may be due to their blockade of potassium channels. Proc Natl Acad Sci USA 78: 7792-7796
5. Anden N-E, Rubenson R, Fuxi K, Hökfelt T (1967) Evidence for dopamine receptor stimulation by apomorphine. J Pharmacol Pharm 19: 627-629
6. Anis WA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-D-aspartate. Br J Pharmacol 79: 565-575
7. 3H] dopamine from chopped striatal tissue. Neuropharmacology 21: 639-645
8. Bagchi SD (1981) Effects of phencyclidine on synaptosomal dopamine continuously appearing from phenylalanine: sensitivity to reserpine. Neuropharmacology 20: 845-851
9. Balster RC (1987) The behavioral pharmacology of phencyclidine. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1573-1579
10. Bartschat DK, Blaustein MD (1986) Phencyclidine in low doses selectively blocks a presynaptic voltage-regulated potassium channel in rat brain. Proc Natl Acad Sci USA 83: 189-192
11. Bowyer JF, Spuhler KP, Weiner N (1984) Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes. J Pharmacol Exp Ther 229: 671-680
12. 3H] dopamine from striatal slices. J Pharmacol Exp Ther 257: 262-270
13. Bristow LJ, Hutson PH, Thorn L, Tricklebank MD (1993) The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br J Pharmacol 108: 1156-1163
14. Bustos G, Abarca J, Forray MI, Gysling K, Bradberry CW, Roth RH (1992) Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies. Brain Res 585: 105-115
15. Carboni E, Imperato A, Perezzani L, DiChiara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extra-cellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28: 653-666
16. Carlsson M, Carlsson A (1989a) Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. J Neural Transm 77: 65-71
17. Carlsson M, Carlsson A (1989b) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75: 221-226
18. Carlsson M, Svensson A (1990) Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems. Pharmacol Biochem Behav 36: 45-50
19. Chapman CD, Gazzara RA, Howard SG (1990) Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenyl-acetic acid and homovanillic acid in conscious and anesthetized rats. Neuropharmacology 29: 319-325
20. Clark D, Engberg G, Pileblad E, Svensson TH, Carlsson A, Freeman AS, Bunney BS (1985) An electrophysiological analysis of the actions of 3-PPP enantiomers on the nigrostriatal dopamine system. Naunyn-Schmiedeberg's Arch Pharmacol 329: 344-354
21. Clineschmidt BV, Martin GE, Bunting R, Papp NL (1982) Central sympathomimetic activity of (+)-5-methyl-10,11-dihydropyridine L-type calcium channel [a,d] cyclohepten-5,10-amine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev Res 2: 135-145
22. Contreras PC, Contreras ML, O'Donohue TL, Lair CC (1988) Biochemical and behavioral effects of sigma and phencyclidine ligands. Synapse 2: 240-243
23. Criswell HE, Johnson KB, Mueller RA, Breese GR (1993) Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of N-methyl-D-aspartic-acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. J Pharmacol Exp Ther 265: 1001-1010
24. Dall'Olio R, Gandolfi O, Montanaro N (1992) Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat. Psychopharmacology 107: 591-594
25. Deutch AY, Tam S-Y, Freeman AS, Bowers MB Jr, Roth RH (1987) Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Eur J Pharmacol 134: 257-264
26. Doherty JD, Siminovic M, So R, Meltzer HY (1980) The effect of phencyclidine on dopamine synthesis and metabolism in rat striatum. Eur J Pharmacol 65: 139-149
27. Fessler RG, Sturgeon RD, Meltzer HY (1979) Phencyclidine-induced ipsilateral rotation in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra. Life Sci 24: 1281-1288
28. Finnegan KT, Kanner MI, Meltzer HY (1976) Phencyclidine-induced rotational behavior in rats with nigrostriatal lesions and its modulation by dopaminergic and cholinergic agents. Pharmacol Biochem Behav 5: 651-660
29. Fontana DJ, Post RM, Pert A (1993) Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res 629: 31-39
30. Freed WJ, Bing LA, Wyatt RJ (1984) Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice. Neuropharmacology 23: 175-181
31. Freeman AS, Bunney BS (1984) The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. Eur J Pharmacol 104: 287-293
32. French ED, Ceci A (1990) Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci Lett 119: 159-162
33. French ED, Vantini G (1984) Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants. Psychopharmacology 82: 83-88
34. French ED, Ferkany J, Abreu M, Levenson S (1991) Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine. Neuropharmacology 30: 1039-1046
35. French-Mullen JMH, Rogawski MA (1989) Interaction of phencyclidine with voltage-dependent potassium channels in cultured rat hippocampal neurons: comparison with block of the NMDA receptor-ionophore complex. J Neurosci 9: 4051-4061
36. Gandolfi O, Rimondini R, Dall' Olio R (1992) The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms. Neuropharmacology 31: 1111-1114
37. 3H-catecholamines by rat striatal and hypothalamic synaptosomes. Life Sci 18: 1105-1110
38. 2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK-801. J Neural Transm 4: 15-26
39. Halpain S, Girault JA, Greengard D (1990) Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 343: 369-372
40. Hernandez L, Auerbach S, Hoebel BG (1988) Phencyclidine (PCP) injected into the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis. Life Sci 42: 1713-1723
41. Hiramatsu M, Cho AK, Nabeshima T (1989) Comparison of the behavioral and biochemical effects of the NMDA receptor antagonist, MK-801 and phencyclidine. Eur J Pharmacol 166: 359-366
42. 14C-tyrosine. Arch Int Pharmacodyn 202: 252-258
43. Hondo H, Yonezawa Y, Nakamura T, Nakamura K, Hirano M, Ushimura H, Tashiro N (1994) Effects of phencyclidine on dopamine release in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res 633: 337-342
44. Imperato A, Scrocco MG, Bacchi S, Angelucci L (1990) NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur J Pharmacol 187: 555-556
45. Iyengar S, Dilworth VM, Mick SJ, Contreras C, Monahan JB, Rao TS, Wood L (1990) Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors. Brain Res 524: 322-326
46. Jackisch R, Link T, Neufang B, Koeh R (1992) Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopamino-mimetic or antimuscarinic properties. Arch Pharmacodyn 320: 21-42
47. 3H-PCP binding. Pharmacol Biochem Behav 22: 731-735
48. Kanner M, Finnegan K, Meltzer HY (1975) Dopaminergic effects of phencyclidine in rats with nigrostriatal lesions. Psychopharmacol Commun 1: 393-401
49. Kashihara K, Hamamura T, Okumura K, Otsuki S (1990) Effect of MK-801 on endogenous dopamine release in vivo. Brain Res 528: 80-82
50. Kelly DH, Moore KE (1976) Mesolimbic dopamine neurons in the rotational model of nigrostriatal function. Nature 263: 695-696
51. Kiss J, Toth E, Lajtha A, Vizi ES (1994) NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study. Brain Res 641: 145-148
52. Klockgether T, Twiski L (1990) NMDA antagonists potentiate antiparkinsonian actions of L-DOPA in monoamine-depleted rats. Ann Neurol 28: 539-546
53. Koek W, Colpaert FC, Woods JH, Kamenka J-M (1989) The phencyclidine (PCP) analog N-[1-(2 benzodiazepine (B) thiophenyl) cyclohexyl] piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801. J Pharmacol Exp Ther 250: 1019-1027
54. Krebs MO, Desce JM, Kemel ML, Gaucy C, Godeheu G, Cheramy A, Glowinski J (1991) Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem 56: 81-85
55. Lascher W, Hanock D (1992) The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur J Pharmacol 215: 199-208
56. Lascher W, Annies R, Hanock D (1991) The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci Lett 128: 191-194
57. Liljequist S, Ossowska K, Grabowska-Anden M, Anden N-E (1991) Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 195: 55-61
58. Maj J, Rogoz Z, Skuza G (1991a) Locomotor hyperactivity induced by MK-801 in rats. Pol J Pharmacol Pharmacol 43: 449-458
59. Maj J, Rogoz Z, Skuza G (1991b) Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats. J Neural Transm 85: 169-179
60. Marek D, Chapman CD, Howard S (1992) The effect of phencyclidine and dl-2-amino-5-phosphonovaleric acid on N-methyl-D-aspartic acid induced changes in extracellular concentrations of dopamine and dopac in the rat neostriatum. Neuropharmacology 31: 123-127
61. Marshall JF, O'Dell SJ, Weihmuller FB (1993) Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. J Neural Transm 91: 241-254
62. 3H] dopamine in the striatum of the conscious rat. In: In vivo perfusion and release of neuroactive substances. Academic Press, New York, pp 293-314
63. Martin GE, Papp NL (1984) Blockade of MK-801 induced ipsiversive turning in 6-OHDA lesioned rats by alpha-1-adrenoceptor antagonists. Pharmacol Biochem Behav 20: 893-897
64. Maurice T, Vignon J, Kamenka J-M, Chicheportiche R (1991) Differential interaction of phencyclidine-like drugs with the dopamine uptake complex in vivo. J Neurochem 56: 553-559
65. McCullough LD, Salamone JD (1992) Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Res 577: 1-9
66. Mele A, Fontana D, Pert A (1997a) Alterations in striatal dopamine overflow during rotational behavior induced by amphetamine, phencyclidine and MK-801. Synapse 26: 218-224
67. Mele A, Thomas DN, Pert A (1997b) Different neural mechanisms underlie MK-801 and dopamine agonist induced locamotor activity. Neuroscience (in press)
68. Meltzer HY, Fessler RG, Siminovic M, Sturgeon D (1979) PCP: neurochemistry, treatment, and more. Am J Psychiatry 136: 235
69. Meltzer HY, Sturgeon D, Siminovic M, Fessler RG (1981) Phencyclidine as an indirect dopamine agonist. In: Domino EF (ed) PCP (phencyclidine): historical and current perspectives. NPD Books, Ann Arbor, pp 207-242
70. Morari M, O'Connor WT, Ungerstedt U, Fuxe K (1993) N-Methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: an in vivo microdialysis study. J Neurochem 60: 1884-1893
71. 2 responses in the 6-hydroxydopamine model of Parkinson's disease. Eur J Pharmacol 182: 611-612
72. Ohmori T, Koyama T, Nakamura F, Wang P, Yamashita I (1992) Effect of phencyclidine on spontaneous and N-methyl-D-aspartate (NMDA)-induced efflux of dopamine from superfused slices of rat striatum. Neuropharmacology 31: 461-467
73. Ouagazzal A-M, Nicoullon A, Amalric M (1994) Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. Eur J Pharmacol 251: 229-236
74. Pawlowski L, Mathe JM, Svensson T (1990) Phencyclidine activates rat A10 dopamine neurons but reduces burst activity and causes regularization of firing. Acta Physiol Scand 139: 529-531
75. Raffa RB, Ortegon ME, Robisch DM, Martin GE (1989) In vivo demonstration of the enhancement of MK-801 by l-glutamate. Life Sci 44: 1593-1599
76. Rao TS, Kim HS, Lehmann J, Martin LL, Wood L (1990a) Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat. J Neurochem 54: 1157-1162
77. Rao TS, Kim HS, Lehmann J, Martin LL, Wood L (1990b) Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors. Neuropharmacology 29: 225-230
78. Reid AA, Mattson MV, deCosta BR, Thurkauf A, Jacobson AE, Monn JA, Rice KC, Rothman RB (1990) Specificity of phencyclidine-like drugs and benzomorphan opiates from two high affinity phencyclidine binding sites in guinea pig brain. Neuropharmacology 29: 811-817
79. Rogawski MA, Pieniek M, Suzuki S, French-Mullen JMH (1988) Phencyclidine selectivity blocks the sustained voltage-dependent potassium conductance in PC 12 cells. Brain Res 456: 38-45
80. Rossetti ZL, Hmaidan Y, Gessa GL (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol. morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221: 227-234
81. Rolhman RB, Reid AA, Monn JA, Jacobson AE, Rice KC (1989) The psychomimetic drug pheneyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites. Mol Pharmacol 36: 887-895
82. Smith AD, Balam JP (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci 13: 259-265
83. 3H] serotonin uptake in synaptosomal preparations from rat brain. Biochem Pharmacol 26: 1435-1439
84. Snell LD, Johnson KM (1985) Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. J Pharmacol Exp Ther 235: 50-57
85. Snell LD, Mueller ZL, Gannon RL, Silverman B, Johnson KM (1984) A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo. J Pharmacol Exp Ther 231: 261-269
86. Snell LD, Yi S-J, Johnson KM (1988) Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release. Eur J Pharmacol 145: 223-226
87. Steinfels GF, Tam SW (1989) Selective δ receptor agonist and antagonist affect dopamine neuronal activity. Eur J Pharmacol 163: 167-170
88. Steinpreis RE, Salamone JD (1993) The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Res 612: 263-270
89. St-Pierre JA, Bedard J (1994) Intranigral but not intrastriatal micro injection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model. Brain Res 660: 255-260
90. Sturgeon RD, Fessler RG, Meltzer HY (1979) Behavioral rating scales for screening phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 59: 169-179
91. 3H] Ethylketocyclazocine, u, k, δ and phencyclidine binding sites in guinea pig brain membranes. Eur J Pharmacol 109: 33-41
92. Tanii Y, Nishikawa T, Umino A, Takahashi K (1990) Phencyclidine increases extracellular dopamine metabolites in rat medial frontal cortex as measured by in vivo dialysis. Neurosci Lett 112: 318-323
93. Tiedtke PI, Bischoff C, Schmidt WJ (1990) MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm 81: 173-182
94. Tricklebank MD, Singh L, Oles RJ, Wong EHF, Iversen SD (1987) A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine. Eur J Pharmacol 141: 497-501
95. Ungerstedt U (1971) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand Suppl 367: 49-67
96. 3H-dopamine accumulation by rat brain striatal slices. Subst Alcohol Action Misuse 1: 351-354
97. Vickroy TW, Johnson KM (1982) Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices. J Pharmacol Exp Ther 223: 669-674
98. Vickroy TW, Johnson KM (1983) Effects of phencyclidine on the release and synthesis of newly formed dopamine. Neuropharmacology 22: 839-842
99. 3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex. Eur J Pharmacol 148: 427-436
100. Vincent JP, Cauey D, Kamenka JM, Geneste P, Ladunski M (1978) Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system. Brain Res 152: 176-182
101. Wachtel SR, White EJ (1988) Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. J Pharmacol Exp Ther 244: 410-416
102. Wedzany K, Golembiowska K, Klimek V (1993a) MK-801-induced symptoms of sensitization. The lack of correlation with the extracellular concentration of dopamine in the rat prefrontal cortex. Brain Res 625: 333-336
103. 1 receptors. Brain Res 622: 325-329
104. Weihmuller FB, O-Dell SJ, Cole BN, Marshall JE (1991) MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study. Brain Res 549: 230-235
105. Weihmuller FB, O'Dell SJ, Marshall JF (1992) MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 11: 155-163
106. Whitton PS, Biggs CS, Pearce BR, Fowler LJ (1992) Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neurosci Lett 142: 5-8
107. Willins DL (1993) The role of dopamine and AMDA/kainate receptors in the nucleus accumbens in the hypermotility response to MK-801. Pharmacol Biochem Behav 46: 881-887
108. Wong EHF, Kemp JA (1991) Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Annu Rev Pharmacol Toxicol 31: 401-425
109. Yamaguchi K, Nabeshima T, Kameyama T (1986) Role of dopaminergic and gabaergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior. J Pharmacobiol Dyn 9: 975-986
110. Zetterstrom T, Sharp T, Collini AK, Ungerstedt U (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs: implications for the origin of extracellular DOPAC. Eur J Pharmacol 148: 327-334